Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: NEO-REEDUC - Mixed Reality for Motor Rehabilitation: a Prospective, Multicenter, Controlled, Randomized, Open Study. [NA]
NEO-REEDUC is a prospective, multicenter randomized open-label trial evaluating mixed-reality motor rehabilitation across several neurologic…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Mediterranean Diet Effects on Parkinson's Disease [NA]
A clinical trial investigating the effects of a Mediterranean diet on Parkinson's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease [NA]
A clinical trial update for ARC-IM Therapy to alleviate locomotor deficits in Parkinson's disease. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Long Term Follow Up KET-PD
An ongoing Yale-sponsored long-term follow-up study (KET-PD) for Parkinson's disease, including depressive symptoms, is currently enrolling …
-
FDA approval · 2025-07-10FDA Approved: AMANTADINE HCL — Supplemental Application (Bionpharma Inc.)
FDA approves a supplemental application for amantadine hydrochloride submitted by Bionpharma Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Amantadine Hydrochloride from Upsher-Smith Laboratories, authorizing a generic product with appr…
-
FDA approval · 2025-07-10FDA Approved: GOCOVRI — Supplemental Application (Adamas Pharma, LLC)
The FDA approved a supplemental application for GOCOVRI (amantadine) submitted by Adamas Pharma, LLC.
-
FDA label_change · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for Amantadine Hydrochloride (Advagen Pharma Limited), likely implementing labeling changes for this…
-
FDA approval · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Inc.)
FDA approves a supplemental application for Amantadine Hydrochloride submitted by Strides Pharma Inc., updating its approval scope under an …
-
FDA approval · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Amantadine Hydrochloride by Zydus Lifesciences Limited.
-
FDA approval · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental ANDA for Amantadine Hydrochloride by Rising Pharma Holdings, Inc., enabling the marketing of the generic pro…
-
FDA label_change · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for amantadine hydrochloride submitted by Upsher-Smith Laboratories, LLC, likely resulting in labeli…
-
FDA approval · 2025-07-10FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (BAJAJ MEDICAL, LLC)
FDA approved a supplemental application for Amantadine Hydrochloride from Bajaj Medical, LLC.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: MIBG in Aging and Neurologic Disorders [Phase 4]
Mayo Clinic is leading a Phase 4 trial of MIBG in aging and neurologic disorders, with enrollment by invitation, studying Lewy body dementia…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Steps Against the Burden of Parkinson's Disease - RCT Kiel [NA]
An ongoing randomized controlled trial at the University of Kiel is evaluating strategies to reduce burden in Parkinson disease, including f…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton [NA]
A clinical trial update announcing recruitment for a study evaluating a robotic exoskeleton (EksoSkeleton) to enhance treatment for Parkinso…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients [Phase 3]
Phase 3 trial evaluating metformin as add-on therapy to levodopa in Parkinson's disease; the study is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease [Phase 2]
A Phase 2 trial assessing dose optimization of nicotinamide riboside in Parkinson disease has completed.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases [Phase 1]
Phase 1 trial update for hUC-MSC-sEV-001 nasal drops across several neurodegenerative diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Prevent Cognitive Decline in GBA-associated Parkinson's Disease [Phase 2]
This Phase 2 clinical trial update concerns a study aimed at preventing cognitive decline in patients with GBA-associated Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Effect of AI Chatbot-Assisted Versus Traditional Case-Based Learning on Clinical Reasoning in Occupational Therapy Students: A Study on Parkinson's Disease [NA]
A completed study comparing AI chatbot-assisted learning to traditional case-based learning for developing clinical reasoning in occupationa…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Repurposing Lithium for Parkinson's Disease: a RCT [Phase 1, Phase 2]
A clinical trial update on repurposing Lithium for Parkinson disease, describing a randomized controlled study in Phase 1 and Phase 2 that i…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder [NA]
An update on a clinical trial studying prodromal neurodegeneration in serotonergic-induced REM sleep behavior disorder. The study is current…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease [NA]
A completed clinical trial evaluating an adaptive deep brain stimulation algorithm for personalized therapy in Parkinson disease; results we…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: STEM-PD Open Label Extension (OLE) [NA]
STEM-PD open-label extension trial sponsored by Scion NeuroStim has terminated, with results posted.